Literature DB >> 25562160

Desipramine ameliorates Cr(VI)-induced hepatocellular apoptosis via the inhibition of ceramide channel formation and mitochondrial PTP opening.

Lei Luo1, Ying Xie, An Wang, Xinmin Liu, Fang Xiao, Xiali Zhong, Caigao Zhong.   

Abstract

BACKGROUND: Hexavalent chromium (Cr(VI)) is a common environmental pollutant. Cr(VI) exposure can lead to severe damage in the liver, but the preventive measures to diminish Cr(VI)-induced hepatotoxicity need further study. Acid sphingomyelinase (ASMase) is responsible for the production of ceramide via the hydrolysis of sphingomyelin. The present study was designed to investigate effects of desipramine (DES), as an ASMase inhibitor, on Cr(VI)-induced hepatotoxicity.
METHODS: L-02 hepatocytes were incubated with different concentrations of Cr(VI) for 24h, and ASMase activities and ceramide levels were measured. Moreover, the study investigated the role of DES played in ASMase activities and ceramide levels. Finally, effects of DES on mRNA and protein expressions of the components of mitochondrial permeability transition pore (PTP) and PTP opening were detected.
RESULTS: The ASMase activities and ceramide contents increased in L-02 hepatocytes treated with Cr(VI). The results demonstrated that apoptosis rates, ASMase activities and ceramide content decreased in groups treated with the combination of DES and Cr(VI) compared to Cr(VI) groups. Furthermore, DES inhibited Cr(VI)-induced mitochondrial PTP opening by intervening the mRNA and protein expressions of the components of mitochondrial PTP.
CONCLUSIONS: DES may exert protective effects on Cr(VI)-induced hepatocellular apoptosis probably by inhibiting ceramide channel formation and mitochondrial PTP opening.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25562160     DOI: 10.1159/000369657

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  2 in total

1.  Ontological approach to the knowledge systematization of a toxic process and toxic course representation framework for early drug risk management.

Authors:  Yuki Yamagata; Hiroshi Yamada
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

2.  Cytoprotection of rat hepatocytes by desipramine in a model of simulated ischemia/reperfusion.

Authors:  Jun-Kyu Shin; Jae-Sung Kim
Journal:  Biochem Biophys Rep       Date:  2021-07-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.